• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Prevention and Treatment of COVID-19-Associated Mucormycosis
AbstractPurpose of reviewThe present article will describe the unique factors present in COVID-19 patients that predispose these individuals to develop mucormycosis with emphasis placed on the prevention and treatment of COVID-19-associated mucormycosis (CAM).Recent findingsViral specific factors, pre-existing diabetes mellitus, and COVID-19 treatments combine to facilitate the development of mucormycosis. There appears to be a gross overutilization of steroid and antibiotic therapy among COVID-19 patients. Appropriate stewardship of antibiotic and steroid therapy in conjunction with tight glucose control may prevent the d...
Source: Current Treatment Options in Allergy - July 4, 2023 Category: Allergy & Immunology Source Type: research

Study unravels antibiotic resistance in MRSA ‘superbug’ infections
FINDINGSResearchers applied a new approach pioneered at UCLA to predict whichmethicillin-resistant Staphylococcus aureus, or MRSA,infections willfail to respond toantibiotic treatment. By focusing on epigenetics — changes to gene expression that can’t be detected by standard DNA sequencing — the study examined how the immune system recognizes dangerous superbugs and works with antibiotics to clear them.BACKGROUNDThe Staphylococcus aureus bacterium can  live harmlessly on a person’s skin and in their nose, occasionally causing mild infections that can be treated with standard antibiotics. When itentersthe bloodstre...
Source: UCLA Newsroom: Health Sciences - March 3, 2021 Category: Universities & Medical Training Source Type: news